Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 8

1.

Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53.

Michalovitz D, Halevy O, Oren M.

Cell. 1990 Aug 24;62(4):671-80.

PMID:
2143698
[PubMed - indexed for MEDLINE]
2.

The p53 tumor suppressor gene and gene product.

Levine AJ.

Princess Takamatsu Symp. 1989;20:221-30. Review.

PMID:
2488233
[PubMed - indexed for MEDLINE]
3.

The oncogenic roles of p53 mutants in mouse models.

Lozano G.

Curr Opin Genet Dev. 2007 Feb;17(1):66-70. Epub 2007 Jan 8. Review.

PMID:
17208429
[PubMed - indexed for MEDLINE]
4.

Biochemical, immunological, and functional aspects of the growth-suppressor/oncoprotein p53.

Montenarh M.

Crit Rev Oncog. 1992;3(3):233-56. Review.

PMID:
1616956
[PubMed - indexed for MEDLINE]
5.

p53 mutation heterogeneity in cancer.

Soussi T, Lozano G.

Biochem Biophys Res Commun. 2005 Jun 10;331(3):834-42. Review.

PMID:
15865939
[PubMed - indexed for MEDLINE]
6.

p53: oncogene or anti-oncogene?

Lane DP, Benchimol S.

Genes Dev. 1990 Jan;4(1):1-8. Review. No abstract available.

PMID:
2137806
[PubMed - indexed for MEDLINE]
Free Article
7.

The p53 tumour suppressor gene.

Levine AJ, Momand J, Finlay CA.

Nature. 1991 Jun 6;351(6326):453-6. Review.

PMID:
2046748
[PubMed - indexed for MEDLINE]
8.

[Interaction of oncogene and anti-oncogene products].

Zang J, Zhou AR.

Sheng Li Ke Xue Jin Zhan. 1991 Jan;22(1):34-7. Review. Chinese. No abstract available.

PMID:
1829543
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk